{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:09:57Z","timestamp":1775862597531,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"RISE-Health@RISE, Faculty of Medicine, University of Porto"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Recurrent vulvovaginal candidosis (RVVC), defined as three or more episodes of vulvovaginal candidosis (VVC) within a 12-month period, is a common and debilitating condition that affects a significant percentage of reproductive-aged women, negatively impacting their quality of life. This review aimed to synthesize the most recent scientific data on the pathophysiological mechanisms triggering primary or idiopathic RVVC. Three databases (PubMed, Scopus, and Web of Science) were searched for studies published between 2014 and 2024. Twelve studies were included, covering prospective cohort, cross-sectional, and case\u2013control studies conducted in different countries. The results indicate that recurrence may be related to both intrinsic characteristics of the pathogen, such as increased virulence attributes of Candida spp., and host immune system dysregulation, including alterations in Th1\/Th17 and Th2\/Treg cytokine levels, decreased levels of mannose-binding lectin (MBL), impaired neutrophil and lymphocyte function, and overexpression of CD163+ macrophages and NLRP3 inflammasome. Additionally, genetic factors, such as polymorphisms in the MBL2, IL-12, NLRP3, and TLR2 genes, are associated with increased susceptibility to RVVC. In conclusion, RVVC appears to involve a complex interaction between pathogen virulence and an altered host immune response, which reinforces the need for further investigations to develop personalized therapeutic strategies.<\/jats:p>","DOI":"10.3390\/jof11050357","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T03:05:15Z","timestamp":1746414315000},"page":"357","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recurrent Vulvovaginal Candidosis and Its Underlying Mechanisms: A Systematic Review"],"prefix":"10.3390","volume":"11","author":[{"given":"Maria","family":"Lobo","sequence":"first","affiliation":[{"name":"RISE-Health, Department of Pathology, Microbiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9171-1503","authenticated-orcid":false,"given":"Catarina","family":"Cerqueira","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, ULS Braga, 4710-243 Braga, Portugal"}]},{"given":"Ac\u00e1cio Gon\u00e7alves","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Pathology, Microbiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-8902","authenticated-orcid":false,"given":"Carmen","family":"Lisboa","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Pathology, Microbiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"},{"name":"Department of Dermatology and Venereology, ULS S\u00e3o Jo\u00e3o, 4200-319 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajog.2015.06.067","article-title":"Recurrent vulvovaginal candidiasis","volume":"214","author":"Sobel","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.annepidem.2017.08.010","article-title":"Recurrent vulvovaginal candidiasis","volume":"27","author":"Blostein","year":"2017","journal-title":"Ann. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/sti.74.5.334","article-title":"Psychological factors associated with recurrent vaginal candidiasis: A preliminary study","volume":"74","author":"Irving","year":"1998","journal-title":"Sex. Transm. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1477-7525-11-169","article-title":"Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA","volume":"11","author":"Aballea","year":"2013","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20503121221115201","DOI":"10.1177\/20503121221115201","article-title":"Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis","volume":"10","author":"Neal","year":"2022","journal-title":"SAGE Open Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00404-015-3774-2","article-title":"The dynamic changes of vaginal microecosystem in patients with recurrent vulvovaginal candidiasis: A retrospective study of 800 patients","volume":"292","author":"Yue","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1111\/j.1439-0507.2010.01965.x","article-title":"Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia","volume":"54","author":"Amouri","year":"2011","journal-title":"Mycoses"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1128\/JCM.43.5.2155-2162.2005","article-title":"Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases","volume":"43","author":"Richter","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM198612043152305","article-title":"Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy","volume":"315","author":"Sobel","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa033114","article-title":"Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis","volume":"351","author":"Sobel","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"613.e1","DOI":"10.1016\/j.ajog.2008.06.029","article-title":"Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)","volume":"199","author":"Donders","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejogrb.2012.12.001","article-title":"Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: A systematic review and meta-analysis","volume":"167","author":"Rosa","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_16","unstructured":"(2025, February 21). Available online: https:\/\/www.Nhlbi.Nih.Gov\/Health-Topics\/Study-Quality-Assessment-Tools."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ge, G., Yang, Z., Li, D., Zhang, N., Chen, B., and Shi, D. (2022). Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.959740"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"104893","DOI":"10.1016\/j.meegid.2021.104893","article-title":"Genetic diversity and molecular epidemiology of Candida albicans from vulvovaginal candidiasis patients","volume":"92","author":"Tian","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"myae091","DOI":"10.1093\/mmy\/myae091","article-title":"Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis","volume":"62","author":"Torres","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e13720","DOI":"10.1111\/myc.13720","article-title":"Patients with recurrent vulvovaginal candidiasis exhibit a decrease in both the fungicidal activity of neutrophils and the proliferation of peripheral blood mononuclear cells","volume":"67","author":"Posada","year":"2024","journal-title":"Mycoses"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/myc.12723","article-title":"Is mannose-binding lectin serum concentration a reliable predictor for recurrent vulvovaginal candidiasis?","volume":"62","author":"Ghazanfari","year":"2019","journal-title":"Mycoses"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hammad, N.M., El Badawy, N.E., Nasr, A.M., Ghramh, H.A., and Al Kady, L.M. (2018). Mannose-Binding Lectin Gene Polymorphism and Its Association with Susceptibility to Recurrent Vulvovaginal Candidiasis. Biomed. Res. Int., 2018.","DOI":"10.1155\/2018\/7648152"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/jog.15577","article-title":"Inflammatory invasion on human vaginal mucosa correlated with combined drug treatment and recurrence in recurrent vulvovaginal candidiasis","volume":"49","author":"He","year":"2023","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101463","DOI":"10.1016\/j.genrep.2021.101463","article-title":"Genetic variation and up-regulation of IL-12 enhance susceptibility to recurrent vulvovaginal candidiasis","volume":"26","author":"Isakhani","year":"2022","journal-title":"Gene Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10096-016-2600-5","article-title":"Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC","volume":"35","author":"Jaeger","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"myac087","DOI":"10.1093\/mmy\/myac087","article-title":"Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance","volume":"60","author":"Li","year":"2022","journal-title":"Med. Mycol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rosentul, D.C., Delsing, C.E., Jaeger, M., Plantinga, T.S., Oosting, M., Costantini, I., Venselaar, H., Joosten, L.A., van der Meer, J.W., and Dupont, B. (2014). Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis. Front. Microbiol., 5.","DOI":"10.3389\/fmicb.2014.00483"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1007\/s11033-014-3562-2","article-title":"The role of Human Dectin-1 Y238X Gene Polymorphism in recurrent vulvovaginal candidiasis infections","volume":"41","author":"Usluogullari","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/mmy\/myab048","article-title":"Evaluation of overtime phenotypic variation of yeasts in chronic vulvovaginal candidosis cases","volume":"59","author":"Gaspar","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"104471","DOI":"10.1016\/j.micpath.2020.104471","article-title":"Recurrent vulvovaginal Candida spp isolates phenotypically express less virulence traits","volume":"148","author":"Rolo","year":"2020","journal-title":"Microb. Pathog."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Kargar, M.L., Mohammadi, S.R., Roudbary, M., Ghods, N., Haghighi, L., Daneshnia, F., Tavakoli, M., Jafarzadeh, J., and Hedayati, M.T. (2021). A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.655069"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2009.10.008","article-title":"Mannan-binding lectin in women with a history of recurrent vulvovaginal candidiasis","volume":"148","author":"Henic","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1086\/377234","article-title":"Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women","volume":"37","author":"Babula","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijgo.2005.08.024","article-title":"Mannose-binding lectin and vulvovaginal candidiasis","volume":"92","author":"Liu","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kalia, N., Singh, J., Sharma, S., Arora, H., and Kaur, M. (2017). Genetic and Phenotypic Screening of Mannose-Binding Lectin in Relation to Risk of Recurrent Vulvovaginal Infections in Women of North India: A Prospective Cohort Study. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00075"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e00684-17","DOI":"10.1128\/IAI.00684-17","article-title":"Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: \u201cNeutrophil Anergy\u201d","volume":"86","author":"Yano","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_37","first-page":"100266","article-title":"Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources","volume":"13","author":"Davidson","year":"2022","journal-title":"Lancet Reg. Health-Eur."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2249.1998.00525.x","article-title":"Cellular immunity in recurrent vulvovaginal candidiasis","volume":"111","author":"Corrigan","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"ref_39","first-page":"134","article-title":"Recurrent Vulvovaginal Candidiasis: Could It Be Related to Cell-Mediated Immunity Defect in Response to Candida Antigen?","volume":"11","author":"Talaei","year":"2017","journal-title":"Int. J. Fertil. Steril."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-695X.2000.tb01509.x","article-title":"The study of cell-mediated immune response in recurrent vulvovaginal candidiasis","volume":"29","author":"Nawrot","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/21501203.2023.2265664","article-title":"Risk of candidiasis associated with interleukin-17 inhibitors: Implications and management","volume":"15","author":"Bilal","year":"2024","journal-title":"Mycology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/5\/357\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:27:08Z","timestamp":1760030828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/5\/357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jof11050357"],"URL":"https:\/\/doi.org\/10.3390\/jof11050357","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}